Dow Down 0.08% Nasdaq Up 0.26%

Novo Nordisk A/S (NVO)

-NYSE
45.40 Down 0.01(0.02%) 1:07PM EDT - Nasdaq Real Time Price
Prev Close:45.41
Open:45.52
Bid:45.37 x 200
Ask:45.39 x 100
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:45.05 - 45.52
52wk Range:32.20 - 48.42
Volume:635,205
Avg Vol (3m):891,934
Market Cap:119.35B
P/E (ttm):26.12
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVODown 0.02%119.35B
LLYUp 0.50%66.81B
PFEUp 0.45%183.57B
SNYDown 1.94%138.30B

Key Statistics

Forward P/E (1 yr):22.35
P/S (ttm):7.97
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.82
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback